semaglutide

Novo Nordisk won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. from the District Court of The Hague in…

An unlicensed semaglutide-based product that is administered under the tongue is being marketed to private doctors in the…

The Danish drugmaker is fighting for its GLP-1 franchise on multiple fronts — from the courtroom to the…

New Delhi: In a fresh escalation of the battle for dominance in the fast-growing GLP-1 drug market, Novo…

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The…

Johannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa…

The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk’s weight-loss drug Wegovy for…

Novo Nordisk South Africa is set to launch the country’s first and only authorised copy of semaglutide later…

Novo Nordisk said on Friday that India’s drug regulator has approved its blockbuster obesity drug Wegovy for the…

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major…

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic…

Novo Nordisk has taken an interest in a weight-loss implant developed by Californian medtech Vivani Medical, reflecting a…

Novo Nordisk wins Dutch court injunction protecting